Context Therapeutics

(NASDAQ) CNTX

Current Price$2.29

Market Cap$208.57M

Since IPO (2021)-55%

5 YearN/A

1 Year+163%

1 Month-14%

Context Therapeutics Financials at a Glance

Market Cap

$208.57M

Revenue (TTM)

$0.00

Net Income (TTM)

$36.12M

EPS (TTM)

$-0.38

P/E Ratio

-5.91

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$2.29

Volume

43,277

Open

$2.31

Price

$2.29

Volume

43,277

Open

$2.31

Previous Close

$2.29

Daily Range

$2.20 - $2.31

52-Week Range

$0.49 - $3.62

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$2.29

Volume

43,277

Open

$2.31

Previous Close

$2.29

Daily Range

$2.20 - $2.31

52-Week Range

$0.49 - $3.62

CNTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Context Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Martin A. Lehr, MA

Website

www.contexttherapeutics.com

Headquarters

Philadelphia, PA 19103, US

CNTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-46%

Return on Capital

-66%

Return on Assets

-53%

Earnings Yield

-16.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$208.57M

Shares Outstanding

91.88M

Volume

43.28K

Avg. Volume

1.03M

Financials (TTM)

Gross Profit

$124.66K

Operating Income

$39.70M

EBITDA

$39.70M

Operating Cash Flow

$26.39M

Capital Expenditure

$33.95K

Free Cash Flow

$26.42M

Cash & ST Invst.

$66.00M

Total Debt

$112.06K

Context Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$32.28K

N/A

Gross Margin

0.00%

N/A

Market Cap

$208.57M

N/A

Market Cap/Employee

$17.38M

N/A

Employees

N/A

Net Income

$13.03M

-289.6%

EBITDA

$13.77M

-219.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$65.88M

-30.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$112.06K

+4.4%

Return on Assets

-52.74%

N/A

Return on Invested Capital

-65.65%

N/A

Free Cash Flow

$8.94M

-82.2%

Operating Cash Flow

$8.94M

-82.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.13+1.62%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$3.99-0.50%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$3.98+2.58%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$2.10+1.45%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.47+0.00%

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$5.46-1.09%

STTKShattuck Labs, Inc.

STTKShattuck Labs, Inc.$6.99-2.24%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About CNTX

What is the current price of Context Therapeutics?

Context Therapeutics is trading at $2.29 per share.

What is the 52-week range for Context Therapeutics?

Over the past 52 weeks, Context Therapeutics has traded between $0.49 and $3.62.

How much debt does Context Therapeutics have?

As of the most recent reporting period, Context Therapeutics reported total debt of $112,064.

How much cash does Context Therapeutics have on hand?

Context Therapeutics reported $66.00M in cash and cash equivalents in its most recent financial results.

What is Context Therapeutics’s dividend yield?

Context Therapeutics does not currently have a dividend yield.

Context Therapeutics

Context Therapeutics Financials at a Glance

CNTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Context Therapeutics

CNTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Context Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CNTX

What is the current price of Context Therapeutics?

What is the 52-week range for Context Therapeutics?

How much debt does Context Therapeutics have?

How much cash does Context Therapeutics have on hand?

What is Context Therapeutics’s dividend yield?

Premium Investing Services